You just read:

TissueGene Licensee, Kolon Life Science, Partners with Mitsubishi Tanabe Pharma to Develop and Commercialize Invossa™, the World's First Cell-Mediated Gene Therapy for Degenerative Osteoarthritis

News provided by

TissueGene, Inc.

Nov 01, 2016, 11:01 ET